A Study of the Relative Bioavailability of BMS-626529 Administered as BMS-663068 From 150mg Low-dose Extended-release Tablets Compared to 600mg Reference Extended-release Tablets in Healthy Subjects
PHASE1
An oral dose in healthy subjects to determine the relative bioavailabilty o...
A Study to Assess the Effect of High Fat Meal and Increased Gastric pH on the Bioavailability of an Extended Release Formulation of BMS-663068 in Healthy Subjects
PHASE1
The purpose of this study is to estimate the effect of high fat meal and in...
Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
PHASE4
The RECOVER study is a self-controlled case series to evaluate whether the ...